Table 1 Sample characteristics of the study cohort.

From: Selective serotonin reuptake inhibitors and suicidal behaviour: a population-based cohort study

 

Overall

(N = 538,577)

Female

(N = 336,032)

Male

(N = 202,545)

No. individuals at different agesa (%)

 6–17 years

31,280

(5.8 %)

19,533

(5.8%)

11,747

(5.8%)

 18–24 years

91,365

(17.0%)

58,415

(17.4%)

32,950

(16.3%)

 25–39 years

186,571

(34.6%)

117,453

(35.0%)

69,118

(34.1%)

 40–49 years

123,795

(23.0%)

77,476

(23.1%)

46,319

(22.9%)

 50–59 years

105,566

(19.6%)

63,155

(18.8%)

42,411

(20.9%)

No. individuals at different educationb levels (%)

 Compulsory school (≤9 years)

47,887

(8.9%)

27,125

(8.1%)

20,762

(10.3%)

 Upper secondary school

247,278

(45.9%)

150,786

(44.9%)

96,492

(47.6%)

 University

234,399

(43.5%)

152,767

(45.5%)

81,632

(40.3%)

 No information

9013

(1.7%)

5354

(1.6%)

3659

(1.8%)

Mean length of full follow-up, yrs

4.6

 

4.7

 

4.6

 

No. individuals with event (%)

 Year before initiation

6745

(1.3%)

4169

(1.2%)

2576

(1.3%)

  Suicide attempts

6745

(1.3%)

4169

(1.2%)

2576

(1.3%)

 Year after initiation

6385

(1.2%)

4311

(1.3%)

2074

(1.0%)

  Suicide attempts

6080

(1.2%)

4222

(1.3%)

1858

(1.0%)

  Death by suicide

346

(0.1%)

104

(<0.1%)

242

(0.1%)

 Full follow-up

25,090

(4.7%)

15,455

(4.6%)

9635

(4.8%)

  Suicide attempts

23,934

(4.4%)

15,087

(4.5%)

8847

(4.4%)

  Death by suicide

1703

(0.3%)

601

(0.2%)

1102

(0.5%)

  1. aAt first SSRI treatment initiation.
  2. bHighest level of commenced education between the index individual and his/her parents in the calendar year before the year of initiation.